Additional alternatives to Vasostrict (vasopressin) have hit the US market, further shaking up the competitive landscape for the near-billion-dollar brand in the wake of Eagle Pharmaceuticals’ first generic launch in January.
Dr Reddy’s has launched an authorized generic, while Endo’s Par Sterile Products has introduced a new pre-mixed ready-to-use version of...



